Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Acumen Research Laboratory

Request full access

Molecular diagnostic tools for infectious disease detection

ChinaFounded 2010Health

About Acumen Research Laboratory

Acumen Research Laboratories (ARL) is a Singapore-based life sciences company specializing in biomarker discovery and the development of molecular diagnostic tools for infectious diseases. Founded in 2010 by Dr. Ong Siew Hwa, the company operates as a contract research organization (CRO), offering R&D services to the pharmaceutical and biomedical science sectors. Dr. Ong, who holds a Ph.D. in cell and molecular biology, has extensive experience in pharmaceutical R&D and molecular diagnostics and has served as an adjunct assistant professor at the National University of Singapore's Yong Loo Lin School of Medicine.

The company's primary business involves developing and manufacturing PCR-based, culture-independent molecular diagnostic tests. ARL's portfolio includes the patented AcuSept test, a host-response test that uses a panel of mRNA biomarkers to detect sepsis within five hours, a significant improvement over traditional methods. This test is also relevant as a companion diagnostic in sepsis treatment and for guiding clinical trials. In response to the COVID-19 pandemic, ARL developed the Acu-Corona PCR test kits. The company also distributes the Unyvero platform, which detects pathogens and antibiotic resistance markers for conditions like pneumonia, intra-abdominal infections, and blood infections. ARL's client base includes companies developing new antibiotics, diagnostics, and medical devices.

In 2020, Acumen Diagnostics was established as a joint venture with Q & M Dental Group, focusing on rapid PCR-based tests. This entity became a key provider of COVID-19 PCR testing in Singapore. Acumen Research Laboratories was acquired by Aoxin Q&M Dental Group on October 9, 2021, for $29.4 million. However, as of late 2024, Q&M Dental Group decided to suspend Acumen's laboratory business due to its loss-making position following the shift away from mass COVID-19 testing.

Source: Dealroom company data

At a glance

Founded
2010
Headquarters
China
Sector
Health

Acumen Research Laboratory in its local ecosystem

Live from Dealroom

The Acumen Research Laboratory office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Aoxin Q&M Dental Group
Employees 1 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇫🇷 France100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Acumen Research Laboratory on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acumen Research Laboratory on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.